These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25082501)

  • 1. Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure.
    Berezin AE; Kremzer AA
    Diabetes Metab Syndr; 2014; 8(3):138-44. PubMed ID: 25082501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure.
    Berezin AE; Kremzer AA
    J Card Fail; 2014 Jun; 20(6):438-47. PubMed ID: 24594088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure.
    Berezin AE; Kremzer AA; Cammarota G; Zulli A; Petrovic D; Martell-Claros N; Sabo J; Kruzliak P
    Clin Chem Lab Med; 2016 Jul; 54(7):1259-67. PubMed ID: 26656612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Content of circulating endothelial progenitor cells in patients with chronic ischemic heart failure with preserved left ventricular ejection fraction].
    Berezin AE; Kremzer AA
    Kardiologiia; 2015; 55(1):14-22. PubMed ID: 26050484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.
    Berezin AE; Kremzer AA; Martovitskaya YV; Berezina TA; Gromenko EA
    EBioMedicine; 2016 Feb; 4():86-94. PubMed ID: 26981573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients.
    Berezin AE; Kremzer AA; Samura TA; Martovitskaya YV; Malinovskiy YV; Oleshko SV; Berezina TA
    J Cardiol; 2015 May; 65(5):403-11. PubMed ID: 25123603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies.
    Chang HW; Leu S; Sun CK; Hang CL; Youssef AA; Hsieh YK; Yang CH; Cheng CI; Chen SM; Chen CJ; Chua S; Chang LT; Wu CJ; Yip HK
    Transl Res; 2010 Oct; 156(4):251-63. PubMed ID: 20875902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endothelial progenitor cells in congestive heart failure.
    Nonaka-Sarukawa M; Yamamoto K; Aoki H; Nishimura Y; Tomizawa H; Ichida M; Eizawa T; Muroi K; Ikeda U; Shimada K
    Int J Cardiol; 2007 Jul; 119(3):344-8. PubMed ID: 17070610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin is associated with depletion of circulating endothelial progenitor cells and elevation in pulmonary arterial pressure in patients with systolic heart failure.
    Zhang H; Feng L; Wan Q; Hong Y; Li Y; Cheng G; Han X
    Acta Cardiol; 2015 Aug; 70(4):435-41. PubMed ID: 26455246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.
    Michowitz Y; Goldstein E; Wexler D; Sheps D; Keren G; George J
    Heart; 2007 Sep; 93(9):1046-50. PubMed ID: 17277352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of angiotensin-2 receptor blocker valsartan on circulating level of endothelial progenitor cells in diabetic patients with asymptomatic coronary artery disease.
    Berezin AE; Kremzer AA; Martovitskaya YV; Samura TA
    Diabetes Metab Syndr; 2015; 9(4):305-9. PubMed ID: 25470647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood.
    Hristov M; Schmitz S; Schuhmann C; Leyendecker T; von Hundelshausen P; Krötz F; Sohn HY; Nauwelaers FA; Weber C
    Cytometry A; 2009 Oct; 75(10):848-53. PubMed ID: 19739088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics.
    Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R
    Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure.
    White M; Lepage S; Lavoie J; De Denus S; Leblanc MH; Gossard D; Whittom L; Racine N; Ducharme A; Dabouz F; Rouleau JL; Touyz R
    J Card Fail; 2007 Mar; 13(2):86-94. PubMed ID: 17395047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure.
    Kissel CK; Lehmann R; Assmus B; Aicher A; Honold J; Fischer-Rasokat U; Heeschen C; Spyridopoulos I; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2007 Jun; 49(24):2341-9. PubMed ID: 17572250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.